2017
Rituximab-mediated release of CLL cells from lymph nodes to periphery: use of CD62L molecule as a marker.
BORSKÝ, Marek, Jitka NOVOTNÁ, Yvona BRYCHTOVÁ, Michael DOUBEK, Jiří MAYER et. al.Basic information
Original name
Rituximab-mediated release of CLL cells from lymph nodes to periphery: use of CD62L molecule as a marker.
Authors
BORSKÝ, Marek (203 Czech Republic, belonging to the institution), Jitka NOVOTNÁ (203 Czech Republic, belonging to the institution), Yvona BRYCHTOVÁ (203 Czech Republic, belonging to the institution), Michael DOUBEK (203 Czech Republic, belonging to the institution), Jiří MAYER (203 Czech Republic, belonging to the institution) and Martin TRBUŠEK (203 Czech Republic, belonging to the institution)
Edition
International Conference Analytical Cytometry IX, Praha, 2017
Other information
Language
English
Type of outcome
Conference abstract
Field of Study
10606 Microbiology
Confidentiality degree
is not subject to a state or trade secret
RIV identification code
RIV/00216224:14110/17:00098558
Organization unit
Faculty of Medicine
Keywords in English
CLL; cells; release
Changed: 14/2/2018 14:07, Bc. Kateřina Kolesová
Abstract
V originále
Rituximab-mediated release of CLL cells from lymph nodes to periphery: use of CD62L molecule as a marker, Rituximab-mediated release of CLL cells from lymph nodes to periphery: use of CD62L molecule as a marker.
Links
| 16-32743A, interní kód MU (CEP code: NV16-32743A) |
|